Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
NCT00331188 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2008-07-08
Summary
The main objective of this study is to determine the efficacy of early administration of Sanvar® in combination with endoscopic treatment for the control of acute variceal bleeding.
Conditions
- Esophageal Varices
- Portal Hypertension
- Gastric Varices
- Esophageal Bleeding
Interventions
- DRUG
-
Sanvar® (vapreotide)
Sponsors & Collaborators
-
Debiovision
lead INDUSTRY
Principal Investigators
-
Joseph Lim, M.D. · Yale University
-
Tarek Hassanein, M.D. · University of California, San Diego
-
Michael B. Fallon, M.D. · UAB Liver Center, Division of Gastroenterology & Hepatology
-
Daniel R. Ganger, M.D. · Northwestern Memorial Hospital
-
Naga P. Chalasani, M.D. · Indiana University School of Medicine
-
Adrian Reuben, M.D. · Medical University of South Carolina
-
Paul J. Thuluvath, M.D. · The Johns Hopkins Hospital & School of Medicine
-
James F. Trotter, M.D. · University of Colorado, Denver
-
Hugo Vargas, M.D. · Mayo Clinic Scottsdale, Arizona
-
Samuel Sigal, M.D. · Weill Medical College of Cornell University
-
Michele D. Bishop, M.D. · Mayo Clinic Jacksonville Florida
-
Gary A. Abrams, M.D. · Alabama Liver & Digestive Specialists Research Center - Montgomery, AB
-
Robert S. McFadden, M.D. · CHRISTUS Santa Rosa Medical Center - San Antonio, TX
-
Nezam H. Afdhal, M.D. · Beth Israel Deaconess Medical Center, Boston MA
-
Jeffrey S. Crippin, M.D. · Washington University School of Medicine
-
Alvaro Koch, M.D. · University of Kentucky Medical Center - Lexington, KY
-
Kimberly Beavers, M.D., M. Ph. · Mission Hospitals, Inc. - Asheville, NC
-
Arun J. Sanyal, M.D. · Virginia Commonwealth University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-07-31
Countries
- United States
Study Locations
Related Clinical Trials
-
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
NCT05038228 · Status: ACTIVE_NOT_RECRUITING
- Atrial Fibrillation
-
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)
NCT00680186 · Status: COMPLETED · Phase: PHASE3
- Thromboembolism
-
The DARE Warfarin CER Study
NCT03271450 · Status: UNKNOWN
- Deep Venous Thrombosis
- Pulmonary Embolism
-
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
NCT02111564 · Status: COMPLETED · Phase: PHASE3
- Heart Failure
- Respiratory Insufficiency
- Stroke Acute
- +2 more
-
Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants
NCT02161731 · Status: COMPLETED · Phase: PHASE1
- Healthy Volunteers
More Related Trials
-
The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage
NCT02061748 ·Status: COMPLETED
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
NCT02079584 ·Status: COMPLETED
-
A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department
NCT02584660 ·Status: COMPLETED ·Phase: PHASE4
-
A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.
NCT03715725 ·Status: TERMINATED
-
Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
NCT01989845 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
NCT00345618 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Rivaroxaban for CeREbral Venous Thrombosis
NCT03178864 ·Status: COMPLETED ·Phase: PHASE2
-
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NCT06232551 ·Status: RECRUITING ·Phase: NA
-
The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage
NCT02043808 ·Status: COMPLETED
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)
NCT03247569 ·Status: COMPLETED
-
A Prospective Cohort Study on Warfarin Personalized Medication
NCT06428110 ·Status: COMPLETED
-
A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants
NCT01825876 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
NCT01947998 ·Status: COMPLETED
-
Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
NCT02704598 ·Status: UNKNOWN ·Phase: NA
-
A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin
NCT05022758 ·Status: COMPLETED
-
Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction
NCT03359876 ·Status: COMPLETED
-
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
NCT00005684 ·Status: COMPLETED
-
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study
NCT02559856 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD
NCT03277001 ·Status: UNKNOWN ·Phase: NA
-
Rivaroxaban vs. Warfarin in CVT Treatment
NCT04569279 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
NCT03926780 ·Status: COMPLETED ·Phase: PHASE3
-
A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
NCT02591732 ·Status: COMPLETED
-
Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.
NCT01727453 ·Status: COMPLETED ·Phase: PHASE4